TY - JOUR
T1 - Treatment of AIDS-related Kaposi's sarcoma
AU - Northfelt, D. W.
AU - Kahn, J. O.
AU - Volberding, P. A.
PY - 1991
Y1 - 1991
N2 - Kaposi's sarcoma (KS) is the most common malignancy associated with the acquired immunodeficiency syndrome (AIDS). Epidemiologic and molecular studies of AIDS-related KS (AIDS-KS) are being performed to provide a better understanding of the etiology of the disease, so that rational therapy can be devised. Effective palliative treatment is currently available using conventional chemotherapy, radiation therapy, biologic response modifiers, and various local treatment modalities. AIDS-KS is a heterogeneous disease, and therapy must therefore be individualized, with consideration given to the patient's clinical and immunologic status.
AB - Kaposi's sarcoma (KS) is the most common malignancy associated with the acquired immunodeficiency syndrome (AIDS). Epidemiologic and molecular studies of AIDS-related KS (AIDS-KS) are being performed to provide a better understanding of the etiology of the disease, so that rational therapy can be devised. Effective palliative treatment is currently available using conventional chemotherapy, radiation therapy, biologic response modifiers, and various local treatment modalities. AIDS-KS is a heterogeneous disease, and therapy must therefore be individualized, with consideration given to the patient's clinical and immunologic status.
UR - http://www.scopus.com/inward/record.url?scp=0026064014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026064014&partnerID=8YFLogxK
U2 - 10.1016/s0889-8588(18)30442-8
DO - 10.1016/s0889-8588(18)30442-8
M3 - Review article
C2 - 2022595
AN - SCOPUS:0026064014
VL - 5
SP - 297
EP - 310
JO - Hematology/Oncology Clinics of North America
JF - Hematology/Oncology Clinics of North America
SN - 0889-8588
IS - 2
ER -